1 not yet recruiting. 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Not yet recruiting 1 |
Follow trilaciclib: new trials by email Literature Review of trilaciclib trials Research Report on trilaciclib
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Single-arm, Multi-center, Phase II Exploratory Clinical Study to Evaluate the Efficacy and Safety of Trilaciclib in Preventing Myelosuppression Caused by Topoisomerase I Inhibitor Type ADC Drugs Trilaciclib and Topoisomerase I inhibitor type ADC drugs - Tumor Patients | Not applicable | Not yet recruiting | Tianjin Medical University Cancer Institute and Hospital | 96 | 2026-07-01 | 2026-07-30 |
Tianjin Medical University Cancer Institute and Hospital (1)
China (1)